Axiom Biosciences Investor Webinar
Registration
About Event
Join Remo Moomiaie-Qajar, MD, Founder & CEO of Axiom Biosciences, for a live investor webinar. 🧬
Axiom is developing regenerative cell therapies designed to repair brain damage, starting with newborn brain injury and stroke. In our Phase 1 trial, all nine newborns treated were alive at 12 months, compared with about 46% historical first-year mortality in severe brain bleeds.
Remo will share a short overview of our work, then spend most of the session answering your questions live.
📆 Tuesday, November 17
🕚 11am ET / 8am PT
💬 Short overview + live Q&A
Register now to save your seat!
To learn more about Axiom, visit: wefunder.com/axiombiosciences